Binxian Wei - Nov 21, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Director
Signature
/s/ Binxian Wei
Stock symbol
PALI
Transactions as of
Nov 21, 2023
Transactions value $
$0
Form type
4
Date filed
11/24/2023, 04:00 PM
Previous filing
Jun 13, 2023
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Award $0 +5.82K $0.00 5.82K Nov 21, 2023 Common Stock 5.82K Direct F1, F2, F3, F4
transaction PALI Common Stock Options Award $0 +6.88K $0.00 6.88K Nov 21, 2023 Common Stock 6.88K $0.59 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee.
F2 The grants vest fully on the one (1) year anniversary of the grant date.
F3 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F4 N/A.
F5 Each option represents the right to purchase one share of common stock at the exercise price.